Mammalian Sterile20-like kinase 1 (Mst1) is a ubiquitously expressed serine/threonine kinase which represents a member of the rapidly expanding family of enzymes related to the yeast Sterile20 kinase. Although the physiological function of Mst1 and its role in intracellular signalling is still unclear, reports to date suggest that Mst1, similar to its yeast homologue, operates in the MAPK (mitogen-activated protein kinase) pathway and, in this capacity, may represent a putative MAPK kinase kinase kinase. Moreover, there is abundant evidence for a role of this enzyme in apoptosis, where not only is it a target for caspases, but may also serve as an activator of these proteases to amplify the apoptotic signalling pathway. This paper reviews the investigations that have led to our current understanding of the mechanisms by which Mst1 may be activated and thereby contribute to apoptosis.
Introduction
The common, highly evolutionarily conserved intracellular signalling cascades known as MAPK (mitogen-activated protein kinase) modules are involved in the regulation of a variety of cellular processes, such as growth, differentiation and cell death (see [1] for a review). In budding yeast, Ste20 (Sterile20) kinases serve as a link between G-proteincoupled pheromone receptors at the cell membrane and the downstream MAPKs through phosphorylation of the MAPK kinase kinase Ste11. This in turn acts on the MAPK kinase Ste7, which phosphorylates the FUS3 and KSS1 MAPKs (see [2] for a review).
Recently, an accumulating number of kinases homologous with Ste20 have been identified in mammals (see [3] for a review). Based on their structure and regulation, Ste20-like kinases can be broadly divided into two subfamilies; PAKs (p21-activated kinases) and GCKs (germinal centre kinases). All members of the PAK subfamily (PAK1-PAK6) contain an N-terminal p21-binding domain, which may overlap an autoinhibitory domain for PAK1/PAK2/PAK3, and a Cterminal catalytic domain (see [4] for a review). Mammalian PAKs have been suggested to play a role in regulating many cellular processes such as gene transcription, cell morphology and apoptosis [4] .
Members of the GCK subfamily contain an N-terminal catalytic domain and a C-terminal regulatory domain, but lack the p21-binding domain seen in PAKs. To date, approx. 23 kinases belonging to the GCK family have been identified
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in mammalian cells, which can be further divided into eight subgroups based on their structure and function [3, 5] . Although a number of GCKs such as prostate-derived Ste20-like kinase, Nck-interacting kinase and TNIK (Traf2-and Nck-interacting kinase) have been suggested to play a role in cytoskeletal regulation [6] [7] [8] , other members of the GCK family, such as Mst1 (mammalian Ste20-like kinase 1), Mst2, Mst3, haematopoietic progenitor kinase 1 and Ste20-like kinase, may be involved in apoptosis [9] [10] [11] [12] [13] .
In 1996, Lu et al. [14] reported that apoptosis of HL-60, NIH-3T3 and human prostatic tumour (LnCap) cell lines induced by an array of apoptotic stimuli was associated with the activation of a 36 kDa kinase that phosphorylated MBP (myelin basic protein). Although they postulated that the 36 kDa MBP kinase is a common component of diverse signalling pathways leading to cell apoptosis and that it may be a cleavage product of a higher molecular weight enzyme, this protein was not identified until much later as being a cleaved fragment of Mst1. In fact, this enzyme had only been described a year earlier by Creasy and Chernoff [15, 16] who cloned and characterized two serine/threonine kinases based on their homology with Ste20 kinase and named them Mst1 and Mst2 [15, 16] . In unrelated studies, these kinases were found to be activated in NIH-3T3 cells in response to extreme stress [17] and were termed krs-1/krs-2 (where krs stands for kinase responsive to stress). Mst1 (also known as Krs2) was found to be ubiquitously expressed and was detected in all human tissues and cell lines tested [15] .
Caspases and the regulation of Mst1
Mst1 is a 487-amino-acid protein with a predicted molecular mass of 55.7 kDa [15] , although it is more often reported as migrating at 59-63 kDa [9, [18] [19] [20] . The C-terminus regulatory region contains two distinct functional domains, which are required for homo-and/or hetero-dimerization and the regulation of kinase activity [21] . Interestingly, two caspase-cleavage sites have also been identified between the regulatory and catalytic domains at the sequences DEMD 326 S and TMTD 349 G [9, 22, 23] . Cell-free studies suggest that these sites may be selectively cleaved by caspases-3, -6, -7 and -9 at DEMD 326 S and caspases-6 and -7 at TMTD 349 G [22] , to generate catalytically active enzymes of 36 and 40-41 kDa, respectively [22, 23] . This conclusion is supported by a previous study of Graves et al. [9] , who observed that activation of Mst1 in a BJAB cell line coincided with its cleavage at the caspase-cleavage sequence, DEMD 326 S, to release a 36 kDa catalytic subunit that had approx. 10-fold the activity of full-length Mst1. Furthermore, this process was mediated by caspase 3-like proteases and paralleled the onset of apoptosis. Subsequent studies by several groups of investigators have reported that activation of Mst1 is associated with the cleavage and release of the 36-kDa catalytic fragment [10, 18, 19, 24] .
Thus investigations in a number of cell lines, including BJAB, HPB-ALL, Jurkat and HL-60s, have shown Mst1 to be activated by various pro-apoptotic stimuli and cellular stresses, including UV irradiation [14] , retinoic acid [14] , okadaic acid [18, 25] , TNFα (tumour necrosis factor α) [14] , serum starvation [19] , staurosporine [9] , anti-Fas monoclonal antibody [9, 10] , as well as anti-cancer drugs such as cytotrienin A, MT-21, camptothecin, taxol and 5-fluorouracil [18, 24, 26] . Reactive oxygen species may also activate Mst1. In a study in which HL-60 cells were treated with H 2 O 2 , the resulting apoptosis was associated with the cleavage activation of Mst1 [18] . Moreover, caspases probably mediate H 2 O 2 -induced Mst1 activation and apoptosis, since these effects were inhibited by a pan-caspase inhibitor. Importantly, a role for endogenous oxidant-mediated activation of Mst1 was supported by the finding that scavenging of H 2 O 2 with N-acetylcysteine and GSH suppressed cytotrienin-induced Mst activation, whereas N-acetylserine, a compound lacking the scavenging properties, was without effect [18] . The broad nature of the stimuli and the range of the cell systems in which Mst1 is activated imply that this enzyme may be a common component in the diverse signalling pathways leading to apoptosis. In support of this contention, studies in which wild-type or kinase-inactive mutants of Mst1 were overexpressed showed that these induced and inhibited apoptosis respectively [9, 24] . Indeed, in several cell lines, overexpression of Mst1 has been demonstrated to induce apoptotic features such as cell rounding and shrinkage, detachment from substratum, chromatin condensation and DNA fragmentation [9, 23, [27] [28] [29] .
Interestingly, it has been reported that Mst1 may function both upstream and downstream of caspases, since exogenously expressed Mst1 activated caspases, which resulted in its own cleavage [9] . Recently, this observation has been supported by a report showing that promotion of death receptor-induced apoptosis in HeLa cells by stably transfected Mst1 is associated with increased caspase activation [23] . Moreover, findings of Ura et al. [27] suggest a proapoptotic role for the full-length enzyme; although Mst1-induced DNA fragmentation could be attenuated by caspase inhibitors, other morphological changes such as membrane blebbing, cell shrinkage and chromatin condensation could not be suppressed. These observations suggest that Mst1 may be involved in the amplification of caspase signalling as well as the mediation of caspase-induced apoptotic events.
Caspase-mediated cleavage may also regulate the cellular localization of Mst1. Two nuclear export signals and a nuclear localization signal have been identified in the regulatory domain. Under resting conditions, Mst1 has been reported to be exclusively located in the cytoplasm. Removing the two nuclear export signals of Mst1 by caspases or unmasking the nuclear localization sequence results in the translocation of Mst1 into the nucleus, where it promotes chromatin condensation and nuclear fragmentation [23, 28, 30] . After translocation, Mst1 may mediate its effects through nuclear proteins such as DAP4 (death-associated protein 4) and histone H2B [30, 31] . Thus DAP4 has been shown to associate with Mst1 and may promote apoptosis by co-localization and activation of another bound protein, namely p53 [30] . An additional feature of apoptosis is the selective phosphorylation of histone H2B in mammalian apoptotic cells, which is associated with DNA fragmentation [32] . Given that histones serve as a good substrate in the analysis of Mst1 activation in vitro [10, 23] , the recent finding that histone H2B may represent a physiological substrate for Mst1 is not surprising [31] . Indeed, this investigation showed that caspase 3-induced cleavage-activated Mst1 phosphorylates histone H2B at Ser 14 both in vitro and in vivo, which in turn results in the chromatin condensation that is characteristic of apoptosis. Another nuclear protein that may be regulated by Mst1 is ICAD (inhibitor of caspase-activated DNase). Caspasemediated cleavage of ICAD and the subsequent release of caspase-activated DNase have been shown to be necessary for Mst1-induced DNA fragmentation, since transfection of both non-cleavable and wild-type ICAD prevented this process [27] .
Phosphorylation and regulation of Mst1
The presence of a kinase inhibitory domain in the central region of the regulatory domain and a C-terminal dimerization domain led to the suggestion that, physiologically, Mst1 exists as an autoinhibitory homodimer that is activated after posttranslational modification such as phosphorylation and/or cleavage. Although caspase-mediated cleavage removes the C-terminal regulatory domain, which is associated with an increase in Mst1 activity, there is evidence that caspase-mediated cleavage alone cannot activate Mst1 and both phosphorylation and proteolysis are necessary to activate fully this enzyme [22, 23, 29] . Indeed, Lee et al. [ [22, 29] . Of these, Thr 183 and Thr 187 appear to be essential for kinase activity [29] . From their investigations, Glantschnig et al. [29] proposed a model in which phosphorylation of Mst1 at Thr 183 , and possibly Thr 187 , is induced by an existing active Mst1. Phosphorylation at these sites may be further amplified by dimerization and eventually leads to caspase activation and apoptosis. Although Mst1 activity could be enhanced by caspase-3, this was not found to be essential for signalling or morphological features of apoptosis [9, 29] . Furthermore, the possibility of phosphorylation influencing the susceptibility of Mst1 to proteolysis has been demonstrated in vitro and in intact cells by two groups, who showed that autophosphorylation of DEMD 326 S at Ser 327 attenuates caspase cleavage at this site [22, 29] . Moreover, the work of Glantschnig et al. [29] suggests that phosphorylationmediated inhibition of Mst1 cleavage occurs only in the absence of caspase-3 and may therefore serve to limit proteolysis by other caspases (such as caspases-6, -7 and -9) that target this enzyme.
Role of Mst1 in MAPK signalling
The signalling pathway leading to Mst1 activation has not been examined. However, studies of Khokhlatchev et al. [33] indicate that cellular Mst1 may be constitutively bound to NORE, a protein that is similar to the putative tumour suppressor RASSF1 [33] . Indeed, the NORE-Mst1 complex has been shown to mediate a pro-apoptotic pathway induced by Ras, a protein primarily associated with propagating prosurvival signals [33] .
Little is known about the immediate downstream targets of Mst1. Early studies showed that co-expression of wild-type or C-terminal Mst1 activated p38 MAPK, JNK (c-Jun Nterminal kinase) and their respective upstream kinases MAPK kinases 6 and 7, but did not activate ERK (extracellular-signalregulated kinase) or its upstream kinase MAPK kinase 1 [9, 15] . Moreover, the finding that Mst1-induced JNK activation is mediated by MEKK1 (a MAPK kinase kinase) suggests that Mst1, similar to its yeast homologues, acts like a MAPK kinase kinase kinase [22] . Although a role for p38 MAPK as a downstream target of Mst1 has not been supported in subsequent studies [27] , several investigations have identified JNK as central to mediating the apoptotic effects of Mst1. Thus co-expression studies of Ura et al. [27] have reported that a dominant-negative mutant of JNK inhibited both Mst1-induced morphological changes and caspase activation, and Glantschnig et al. [29] revealed that phosphorylation and activation of Mst1 results in apoptosis via a pathway mediated by JNK and caspases. Similarly, Watabe et al. [24] showed that overexpression of kinase-inactive Mst and transfection of a dominant-negative JNK inhibited the DNA fragmentation induced by MT-21. Furthermore, Mst kinases act upstream of JNK during this process, since MT-21-induced JNK activation could be suppressed by overexpression of the kinase-inactive Mst1 mutant [24] . However, the concept of a linear pathway is challenged by studies showing that, during cytotrienin-induced apoptosis, cleavage activation of Mst1 could be suppressed by caspase inhibitors that did not affect JNK activation [18] , which implies that Mst1 cleavage and JNK activation operate in two distinct pathways. This is in accordance with the results of Watabe et al. [26] , who showed that although cytotrienin-induced cleavage activation of Mst could be almost completely blocked by the overexpression of kinase-inactive Mst1, JNK activation was not affected.
Mst1 and the regulation of leucocyte apoptosis
Although investigations on Mst1 have been primarily performed in human-derived cell lines, only three studies to date have described the Mst1 activation during apoptosis of primary cells. The first showed that bisphosphonateinduced apoptosis of bone-reabsorbing cells (murine-derived osteoclasts) is mediated by caspase-mediated cleavage of Mst1 [19] . More recently, Yamamoto et al. [20] showed that the activation of Mst1, in both cleaved and full-length forms, is associated with apoptosis of neonatal rat cardiac myocytes and is activated by clinically relevant pathological insults. Thus overexpression of Mst1 in cardiac myocytes led to cell shrinkage, caspase cleavage, DNA fragmentation, activation of p38 MAPK/JNK and cleavage of Mst1 itself. To examine the in vivo function of Mst1 in a mouse heart, Yamamoto et al. [20] produced transgenic animals with cardiac-specific overexpression of wild-type and dominantnegative Mst1. They found that overexpression of the wildtype enzyme resulted in increased caspase activation and apoptosis without compensatory hypertrophy. Conversely, in transgenic mice overexpressing dominant-negative Mst1, activity of endogenous Mst1 and myocyte death induced by ischaemic reperfusion were suppressed.
The third set of studies in primary cells was performed in human peripheral blood eosinophils in our laboratory [34] . To our knowledge, this is the only report on Mst1 in human primary cells. During these investigations, we observed a 36 kDa MBP kinase that was temporally associated with constitutive apoptosis of eosinophils. Subsequent immunoprecipitation studies identified this MBP kinase as the cleavage product of a slower migrating MBP kinase (63 kDa), which we identified as Mst1. Although Mst2 was also detected in eosinophils, the 36 kDa kinase activity was not attributed to this enzyme. In eosinophils, cleavage of Mst1 was promoted by pro-apoptotic agents such as Fas receptoractivating monoclonal antibody and dexamethasone ( [34] and P. M. de Souza, P. J. Barnes, M. A. Lindsay and M. A. Giembycz, unpublished work). In contrast, agents that were known to delay apoptosis in eosinophils, such as interleukin-5, granulocyte/macrophage-colony stimulating factor, a pan-caspase inhibitor and an antioxidant, inhibited the cleavage activation of Mst1 that was associated with constitutive and/or Fas-induced apoptosis ( [34] and P. M. de Souza, P. J. Barnes, M. A. Lindsay and M. A. Giembycz, unpublished work). These results indicate that Mst1 may be involved in the apoptotic pathway of eosinophils, a notion supported by the almost exclusive detection of cleaved Mst1 in apoptotic but not in non-apoptotic eosinophils. However, whether Mst1 is essential for eosinophil apoptosis or is merely a by-product of this process remains to be elucidated. Similarly, the downstream targets for this kinase as well as its upstream activators in eosinophils are not currently known. Although it has been suggested that JNK may be a downstream target of Mst1, this seems unlikely given that JNK does not appear to be activated in eosinophils under conditions where Mst1 is activated [35] . However, in agreement with other studies [18] , caspases and H 2 O 2 appear to function upstream of Mst1 cleavage activation during constitutive and Fas-induced apoptosis of eosinophils [34] . An interesting observation that emerged from our studies was that, although eosinophils expressed Mst1, neither full-length nor cleaved Mst1 has been detected in neutrophils by Western-blot analysis [34] . This has been confirmed by 'in-gel' kinase assays, which do not reveal enzyme activities migrating at 36 or 63 kDa, although in neutrophils undergoing apoptosis a 34 kDa MBP kinase is activated. Interestingly, these differences in biochemical pathways may underlie the divergent apoptotic response of eosinophils and neutrophils to a range of drugs, which has raised the possibility of using therapeutic intervention to induce selective death. Thus it has previously been shown that whereas glucocorticoids attenuate neutrophil apoptosis, they induce cell death in eosinophils [36] . Similarly, an inhibitor of p38 MAPK (SB203580) has opposing effects on the cell death of these granulocytes [35, 37] .
Mst1 has recently been implicated in non-apoptotic functions such as proliferation and differentiation [38] [39] [40] [41] [42] , and the role of this kinase in apoptosis is well documented. Indeed, the accumulating evidence for Mst1 in the mediation of apoptosis in diverse cell lines in response to a range of responses, as well as the intimate association between cleavage-induced activation of this enzyme and eosinophil cell death, support the idea that Mst1 probably represents an important regulator of apoptosis in eosinophils. Moreover, the possibility that it may be expressed in some cell types but not in others offers a degree of selectivity in modulating the removal of a specific cell type. To this end, Mst1 could be an important therapeutic target for disorders such as asthma, in which eosinophil levels are linked to disease severity. This work was supported by grants from AstraZeneca Pharmaceuticals and the National Asthma Campaign (grant no. ID 03/070).
